Net Asset Value(s)

MKTUPDTE
Tue, Nov 05 2024 08:30 am

Templeton Emerging Markets Investment Trust PLC ('TEMIT')

On behalf of TEMIT, Franklin Templeton Investment Trust Management Limited reports the unaudited cum-income net asset value ('NAV') of TEMIT as at
01 November 2024 was £2043.104m, representing a NAV of 193.23 pence per share.
The unaudited ex-income NAV of TEMIT as at 01 November 2024 was £2002.651m, representing a NAV of 189.41 pence per share.

In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,
including accumulated or accrued income, and using bid price information relating to the underlying assets.
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.

Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.

If the long-term debt was valued at cost, the cum-income NAV would decrease by 0.10p

For information please contact Client Dealer Services on freephone 0800 305 306.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.


Announcement PDF


Markets News

NZ sharemarket falls 0.6% after Monday's surge
Markets Market close

NZ sharemarket falls 0.6% after Monday's surge

The S&P/NZX 50 Index closed at 13,113.19, declining 82.89 points or 0.63%.

Graham Skellern 26 Nov 2024
Markets

Aroa posts $1.5m HY loss, forecasts annual profit

Auckland surgical products company is forecasting annual profit of between $2m to $6m.

John Anthony 26 Nov 2024
Aroa posts $1.5m HY loss, forecasts annual profit
Markets

Pacific Edge posts $14.5m loss

The cancer diagnostics company is awaiting outcomes of several events.

John Anthony 26 Nov 2024
Pacific Edge posts $14.5m loss